Tumour Microenvironment and Pharmacology Group
The group devises new therapeutic strategies targeting tumour-associated immune landscape, stroma and vasculature.
Dr Olivia Rossanese
Director of the Centre for Cancer Drug Discovery & Head of Division:
Tumour Microenvironment and Pharmacology, Target Evaluation and Molecular Therapeutics
Dr Olivia Rossanese is Director of the Centre for Cancer Drug Discovery and Head of the Division of Cancer Therapeutics. She is investigating new therapeutic targets for the treatment of cancer and examining the molecular consequences of their inhibition in cancer cells and tumours.
Researchers in this group
.
Dr Olivia Rossanese's group have written 41 publications
Most recent new publication 11/2022
See all their publicationsIndustrial partnership opportunities with this group
Opportunity: Discovering and developing small molecule inhibitors of ERAP1
Commissioner: Dr Esther Arwert